Skip to main content
Contact Us
Subscribe
E-Edition
35°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Seer Inc Cl A
(NQ:
SEER
)
2.520
-0.030 (-1.18%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 11, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Seer Inc Cl A
< Previous
1
2
3
4
5
Next >
Seer Ranked Number 57 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™
November 21, 2024
Attributes 2,440% revenue growth to increased adoption of its Proteograph™ Product Suite and exciting discoveries made by Seer customers across multiple areas of biology and disease
From
Seer, Inc.
Via
GlobeNewswire
Seer to Participate in Upcoming November Investor Conferences
November 08, 2024
From
Seer, Inc.
Via
GlobeNewswire
Seer Reports Third Quarter 2024 Financial Results
November 06, 2024
Growing enthusiasm for Proteograph Product Suite with multiple larger orders from government agencies and continued strong interest in STAC
From
Seer, Inc.
Via
GlobeNewswire
Recap: Seer Q4 Earnings
February 29, 2024
Via
Benzinga
Earnings Scheduled For February 29, 2024
February 29, 2024
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.
Via
Benzinga
Seer Enters into a Co-Marketing and Sales Agreement with Thermo Fisher Scientific
November 06, 2024
Collaboration enhances unprecedented access to deep, unbiased proteomics at scale, enabling deeper insights into human biology
From
Seer, Inc.
Via
GlobeNewswire
Seer Highlights Capability of Deep Proteomics to Enhance Genomic Insights Into Alzheimer’s, Lung Cancer, and More at ASHG 2024
October 31, 2024
CoLab session with PrognomiQ and Salk Institute plus multiple presentations of new data offer firsthand look at multi-omic breakthroughs powered by Seer’s Proteograph™ Product Suite
From
Seer, Inc.
Via
GlobeNewswire
Seer Showcases Scalable Proteomic Advancements Impacting Alzheimer’s, Population Health, and Xenotransplantation at HUPO 2024
October 21, 2024
Seer’s Proteograph™ Product Suite reveals new insights into Alzheimer’s pathways, drives population-scale plasma analysis, and captures immune dynamics in xenotransplantation—with additional...
From
Seer, Inc.
Via
GlobeNewswire
Seer to Report Third Quarter 2024 Financial Results on November 6, 2024
October 17, 2024
From
Seer, Inc.
Via
GlobeNewswire
Seer to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
August 22, 2024
From
Seer, Inc.
Via
GlobeNewswire
Seer Appoints Nicolas Roelofs to its Board of Directors
August 14, 2024
From
Seer, Inc.
Via
GlobeNewswire
Seer to Participate in the Canaccord Genuity 44th Annual Growth Conference
August 09, 2024
From
Seer, Inc.
Via
GlobeNewswire
SEER Stock Earnings: Seer Beats EPS, Misses Revenue for Q2 2024
August 08, 2024
SEER stock results show that Seer beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Seer Reports Second Quarter 2024 Financial Results
August 08, 2024
Launched STAC in Europe and additional customer papers published in leading journals
From
Seer, Inc.
Via
GlobeNewswire
Seer to Report Second Quarter 2024 Financial Results on August 8, 2024
July 18, 2024
From
Seer, Inc.
Via
GlobeNewswire
Seer Proteograph™ Provides Differentiated Insights into Spaceflight Proteomic Alterations for Precision Medicine and Biomarker Discovery
June 11, 2024
From
Seer, Inc.
Via
GlobeNewswire
Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ’s Early Cancer Detection Study
June 02, 2024
Combined Workflow of Proteograph™ XT Assay and Thermo Scientific™ Orbitrap™ Astral™ Mass Spectrometer Robustly Identifies over 13,000 Protein Groups Across a Study of 2,840 Subjects
From
Seer, Inc.
Via
GlobeNewswire
SEER Stock Earnings: Seer Meets EPS, Misses Revenue for Q1 2024
May 08, 2024
SEER stock results show that Seer met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Seer Reports First Quarter 2024 Financial Results
May 08, 2024
Demonstrated the power of the Proteograph Product Suite with a growing number of customer presentations and publications
From
Seer, Inc.
Via
GlobeNewswire
Seer Launches New Technology Access Center in Europe to Expand Accessibility to Unbiased Proteomic Solutions
May 08, 2024
From
Seer, Inc.
Via
GlobeNewswire
Seer to Report First Quarter 2024 Financial Results on May 8, 2024
April 23, 2024
From
Seer, Inc.
Via
GlobeNewswire
Seer Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Outlook
February 29, 2024
Enhanced access to the Proteograph Product Suite and demonstrated its power with new customer data
From
Seer, Inc.
Via
GlobeNewswire
Seer to Participate in the TD Cowen 44th Annual Health Care Conference
February 21, 2024
From
Seer, Inc.
Via
GlobeNewswire
Zoom Video And 2 Other Stocks Insiders Are Selling
February 08, 2024
The Nasdaq 100 closed higher by around 1% on Wednesday. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
Seer Proteograph™ Enables Unprecedented Genetic Marker Mapping for Proteogenomics Studies to Advance Drug and Biomarker Discovery
February 06, 2024
From
Seer, Inc.
Via
GlobeNewswire
Seer to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024
February 01, 2024
From
Seer, Inc.
Via
GlobeNewswire
Seer to Present at the J.P. Morgan 42nd Annual Health Care Conference
December 21, 2023
From
Seer, Inc.
Via
GlobeNewswire
Seer to Present at the Canaccord MedTech, Diagnostics and Digital Health & Services Forum
November 10, 2023
From
Seer, Inc.
Via
GlobeNewswire
Seer Wins Proteomics Solution of the Year by BioTech Breakthrough and Named #5 on Deloitte Technology Fast 500
November 08, 2023
Seer technology receives recognition for excellence in the field of proteomics
From
Seer, Inc.
Via
GlobeNewswire
Seer Reports Third Quarter 2023 Financial Results
November 07, 2023
Expanded access to the Proteograph™ Product Suite through the Seer Technology Access Center, new distributors and a new Center of Excellence
From
Seer, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.